The Combined Effect of Modern Highly Active Antiretroviral Therapy Regimens and Adherence on Mortality Over Time

Abstract

Objective To characterize the impact of longitudinal adherence on survival in drug-naive individuals starting currently recommended highly active antiretroviral therapy (HAART) regimens. Methods Eligible study participants initiated HAART between January 2000 and November 2004 and were followed until November 2005 (N = 903). HAART regimens contained efavirenz, nevirapine, or ritonavir-boosted atazanavir or lopinavir. Marginal structural modeling was used to address our objective. Results The all-cause mortality was 11%. Individual adherence decreased significantly over time, with the mean adherence shifting from 79% within the first 6 months of starting HAART to 72% within the 24- to 30-month period (P value < 0.01). Nonadherence over time (<95%) was strongly associated with higher risk of mortality (hazard ratio: 3.13; 95% confidence interval (CI): 1.95 to 5.05). Nonadherent (<95%) patients on nonnucleoside reverse transcriptase inhibitor (NNRTI)–based and boosted protease inhibitor–based regimens were, respectively, 3.61 times (95% CI: 2.15 to 6.06) and 3.25 times (95% CI: 1.63 to 6.49) more likely to die than adherent patients. Within the NNRTI-based regimens, nonadherent individuals on efavirenz were at a higher risk of mortality. Conclusions Incomplete adherence to modern HAART over time was strongly associated with increased mortality, and patients on efavirenz-based NNRTI therapies were particularly at a higher risk if nonadherent. These results highlight the need to develop further strategies to help sustain high levels of adherence on a long-term basis.

Role of the Pharmacist in Caring for Patients with HIV/AIDS: Clinical Practice Guidelines

“…1, [110][111][112] In particular, there is a highly significant correlation between suboptimal adherence and risk of virologic failure, as well as better outcomes with adherence rates over 95%. 113 Newer combination regimens typically consist of coformulated pills of agents with longer half-lives than earlier drugs, which have been shown to be more "forgiving" of imperfect adherence.…”

Effect of Adherence to Anti-Retroviral Therapy on Cd4 T Cells and Hiv Viral Load in Nepalese Tertiary Care Hospital

“…[8] Although treatment for AIDS and HIV exit to decelerate the virus progressing, still there is not exact known cause.…”

Adherence to Antiretroviral Therapy in Managed Care Members in the United States: A Retrospective Claims Analysis

“…3 Like most other adherence studies, this study assumed that adherence was stable and only evaluated adherence for 1 year. An interesting topic for future research …”